Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.

BMC cancer - 13 Apr 2008

Litwiniuk Maria M, Roznowski Krzysztof, Filas Violetta, Godlewski Dariusz D, Stawicka Małgorzata, Kaleta Remigiusz, Breborowicz Jan

Abstract excerpt

BACKGROUND: Breast cancers (BC) in women carrying mutations in BRCA1 gene are more frequently estrogen receptor negative than the nonhereditary BC. Nevertheless, tamoxifen has been found to have a protective effect in preventing contralateral tumors in BRCA1 mutation carriers. The identification of the second human estrogen receptor, ERbeta, raised a question of its role in hereditary breast cancer. The aim of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ductal, Breast
Share to Estrogen Receptor alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Receptor beta

Share to Genes, BRCA1

Share to Genes, erbB-2

Share to Neoplasm Staging

Share to Selective Estrogen Receptor Modulators

Share to Tamoxifen

Source

Open in PubMed Open full text

Identifiers

PMID: 18405391
DOI: 10.1186/1471-2407-8-100
PMCID: PMC2387169

Genes

BRCA1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.PMID 18405391Read ↗

BRCA1-Mutated Estrogen Receptor-Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency.Semantic proximity Read ↗

[Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].Semantic proximity Read ↗

The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.Semantic proximity Read ↗

Is BRCA1/BRCA2-related breast carcinogenesis estrogen dependent?Semantic proximity Read ↗

The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application.Semantic proximity Read ↗

Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Androgen pathway dysregulation in BRCA1-mutated breast tumors.Semantic proximity Read ↗

Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.Semantic proximity Read ↗

Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer.Semantic proximity Read ↗

NRF2 expression level and estrogen function in BRCA1-mutated breast cancer.Semantic proximity Read ↗

BRCA1 mutation, leptin and estrogen levels in breast cancer patients.Semantic proximity Read ↗

Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.